Vassiliki A Boussiotis MD PHD
Hematologist-Oncologist | Hematology & Oncology
100 Blossom St Hematology Oncology Boston MA, 02114About
Dr. Vassiliki Boussiotis is a hematologist oncologist practicing in Boston, MA. Dr. Boussiotis specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Faculty of Medicine Univ of Athens MD
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.
- Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.
- Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).
- Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.
- CTLA-4 regulates cell cycle progression during a primary immune response.
- Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses.
- Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites.
- CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
- Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation.
- cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression.
- T cell anergy and costimulation.
- Differential localization and function of ADP-ribosylation factor-6 in anergic human T cells: a potential marker for their identification.
- Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
Vassiliki A Boussiotis MD PHD's Practice location
Vassiliki Boussiotis
100 Blossom St Hematology Oncology -Boston, MA 02114Get Direction
Vassiliki A Boussiotis MD PHD's reviews
Write ReviewRecommended Articles
![]()
The Blow Self-Image Can Take During Lymphoma TreatmentMany who have endured cancer treatment experience a blow to their self image, and cease to recognize the person looking back at them in the mirror.However, it does not have to be that way! Here are some of the most common changes, and how to cope with them.Skin changesYou may begin to see your skin...
![]()
What are the Stages of Multiple Myeloma?This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...
![]()
How This Survivor Star Beat Hodgkin Lymphoma—TwiceEthan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...
![]()
Genetic Advancements in Lymphoma TreatmentCancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
![]()
Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...
![]()
Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant RecipientsLymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
Nearby Providers
![]()
Dr. YongLi Ji M.D. , PH.D.55 Fruit St Boston MA 02114![]()
Dr. John Erban MD55 Fruit Street Boston MA 02114![]()
Dr. Matthew D Hellmann MDMassachusetts General Hospital Boston MA 02114![]()
Dr. Nathan A Pennell MD PHD55 Fruit St Boston MA 02114![]()
Dr. David R Spriggs MD55 FRUIT ST BOSTON MA 02114![]()
Dr. Steven Lawrence Mcafee MD100 Blossom Street Boston MA 02114
Nearest Hospitals
MASSACHUSETTS EYE AND EAR INFIRMARYl
243 CHARLES STREET BOSTON MA 2114SHRINERS' HOSPITAL FOR CHILDREN - BOSTON, THEl
51 BLOSSOM STREET BOSTON MA 2114